MicroRNAs have been explored for their potential as new therapeutic targets in diabetes vascular complications; for example, Kovacs et al. (82) showed that miR-146 through its inhibition of NF-kβ activation could be a potential therapeutic target in cardiovascular complication of diabetes. The gene discussed is NFKB1; the disease is diabetes mellitus.